¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"positive negative pressure respiration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • negative catalysis
    ¿ªÃ˸ÅÀÛ¿ë
  • negative catalyst
    ¿ªÃ˸ÅÁ¦
  • negative charge
    À½ÀüÇÏ
  • negative convergence
    À½¼º´«¸ðÀ½
  • negative declination
    ³»È¸¼±
  • negative dromotropism
    °¨¼ÒÀüµµ¿µÇ⼺, º¯Á¶°¨¼Ò
  • negative feedback
    À½¼ºµÇ¸ÔÀÓ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
  • negative feeling
    ºÎÁ¤Àû°¨Á¤
  • negative field method
    ºÎÁ¤Á¶»ç¿µ¿ª¹ý
  • negative inotropic
    °¨¼Ò¼öÃà·Â-, À½¼º¼öÃà·Â-
  • negative ion
    À½ÀÌ¿Â
  • negative nitrogen balance
    À½¼ºÁú¼ÒÆòÇü
  • negative phase
    1. À½¼º»ó 2. Ç×ü°¨¼Ò±â
  • negative potential
    À½ÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • negative feedback mechanism
    À½¼ºµÇ¸ÔÀÓ±âÀü
  • negative field method
    ºÎÁ¤Á¶»ç¿µ¿ª¹ý
  • negative staining method
    À½¼º¿°»ö¹ý
  • negative
    ¿ª-, ºÎÁ¤Àû-, À½¼º-
  • negative phase
    À½¼º±â, À½¼º»ó
  • negative potential
    À½ÀüÀ§
  • negative reinforcement
    ºÎÁ¤°­È­
  • negative schizophrenia
    À½¼ºÁ¤½ÅºÐ¿­º´
  • negative scotoma
    À½¼º¾ÏÁ¡, ºñÀνľÏÁ¡
  • negative staining
    ´ëÁ¶¿°»ö, À½¼º¿°»ö
  • negative symptom
    À½¼ºÁõ»ó
  • negative transference
    ºÎÁ¤Àü´Þ
  • negative voltage
    À½Àü¾Ð
  • negative strand RNA
    À½¼º°¡´Ú¾Ë¿£¿¡ÀÌ
  • negative vertical vergence
    À½¼º¼öÁ÷ÀÌÇâ¿îµ¿
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • positive nitrogen balance
    ¾ç¼ºÁú¼ÒÆòÇü.
  • positive phase
    ¾ç¼º»ó(åÕàõßÓ).
  • positive phototaxis
    ¾ç(¼º)ÁÖ±¤¼º.
  • positive placebo =active p.
    ¾ç¼ºÇö󼼺¸, Ç¥Áؾà(øöñÞå·).
  • positive placebo response
    Çö󼼺¸Ä¡·á È¿°ú.
  • positive pole
    ¾ç±Ø(åÕп).
  • positive predictive value (PPV)
    ¾ç¼º ¿¹ÃøÄ¡
  • positive reframing
    ±àÁ¤Àû À籸¼º
  • positive reinforcement
    ¾ç¼º°­È­(¡­Ë­ûù).
  • positive reinforcement
    ¾ç¼º°­È­(¡­Ë­ûù).
  • positive reinforcer
    ¾ç¼º°­È­ÀÚ±Ø(¡­ô§Ð½).
  • positive reinforcer
    ¾ç¼º°­È­ÀÚ±Ø(¡­ô§Ð½).
  • positive scotoma
    ¾ç¼º¾ÏÁ¡(ãùàõäÞïÇ), ÀνľÏÁ¡
  • positive skin test
    ¾ç¼ºÇǺνÃÇè(åÕàõù«Ý± ãËúÐ).
  • positive soap
    ¾ç¼ººñ´©.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • biologic false positive serologic test
    »ý¹°ÇÐÀû °¡¾ç¼º Ç÷û¹ÝÀÀ(¡­Ê£åÕàõ úìôèÚãëë).
  • biological false positive reaction
    »ý¹°ÇÐÀû °¡¾ç¼º ¹ÝÀÀ.
  • biological false positive reaction
    »ý¹°ÇÐÀû °¡¾ç¼º ¹ÝÀÀ.
  • cold agglutinin positive pneumonia
    ÇÑ·©ÀÀÁý¼Ò ¾ç¼ºÆó·Å.
  • cold agglutinin positive pneumonia
    [°áÇÙ,³»°ú]ÇÑ·©ÀÀÁý¼Ò ¾ç¼ºÆó·Å.
  • false positive reaction
    °¡¾ç¼º ¹ÝÀÀ.
  • false positive reaction, biological
    »ý¹°ÇÐÀû °¡¾ç¼º¹ÝÀÀ, »ý¹°ÇÐÀû À§¾ç¼º¹ÝÀÀ
  • gram positive organism
    ±×·¥¾ç¼º¼¼±Õ.
  • hallucination, positive
    ¾ç¼ºÈ¯°¢(åÕàõü³ÊÆ)
  • old agglutinin positive pneumonia
    ÇÑ·©ÀÀÁý¼Ò ¾ç¼º Æó·Å(ùÎÕÒëêó¢áÈåÊàõøË æú).
  • oxidase positive
    »êÈ­È¿¼Ò¾ç¼º(¡­åÕàõ).
  • oxidase-positive glucose fermenter
    »êÈ­È¿¼Ò¾ç¼º Æ÷µµ´ç¹ßÈ¿(Û£ý£)ü
  • positive acceleration
    ¾ç°¡¼Óµµ(Çö»ó)(åÕÊ¥áÜöôúÞßÚ).
  • positive after image
    ¾ç¼ºÀÜ»ó(åÕàõíÑßÀ).
  • positive after potential
    ¾ç¼ºÈÄÀüÀ§(åÕàõý­ï³êÈ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
EPR early progressive resistance; electron paramagnetic resonance; electronic patient record; electrophr...
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
NR do not repeat [Lat. non repetatur]; nerve root; neural retina; neutral red; noise reduction; nonreac...
P&R pelvic and rectal [examination]; pulse and respiration
RC an electronic circuit containing a resistor and capacitor in series; radiocarpal; reaction center; r...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
PEEPi positive and expiratory pressure
PCO2 pressure , carbon dioxide pressure
CNS Coagulase Negative Staphylococci
CNS Coagulase Negative Staphylococcus
CONS Coagulase negative staphylococci
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • coexistent pressure
    °øÁ¸ ¾Ð·Â
  • colloid osmotic pressure
    ÄÝ·ÎÀÌµå »ïÅõ¾Ð, ±³Áú »ïÅõ¾Ð
  • continuous-infusion pressure-monitored
    ¿¬¼Ó ÁÖÀÔ¾Ð ÃøÁ¤
  • deep pressure
    ½ÉºÎ ¾Ð·Â
  • Donders' pressure
    µ·´õ ¾Ð
    ½ÃüÀÇ ÈäºÎ¸¦ Àý°³ÇÏ°í ±â°ü À§¿¡ ¾Ð·Â°è¸¦ ³õÀ¸¸é ¾Ð·ÂÀÌ Áõ°¡µÇ´Âµ¥ ÀÌ´Â Æó°¡ ÇãÅ»À» ÀÏÀ¸Å°±â ¶§¹®ÀÌ´Ù.
  • enddiastolic pressure
    È®Àå ¸»±â ¾Ð
  • endocardial pressure
    ½É³»¾Ð
    ½ÉÀå³»ÀÇ Ç÷¾Ð.
  • filling pressure
    ÃæÀü ¾Ð·Â, ÃæÀü ¾Ð
  • filtrating pressure
    ¿©°ú¾Ð, ¿©°ú ¾Ð·Â
  • free portal pressure
    ÀÚÀ¯ ¹®¸Æ¾Ð
  • hydrostatic pressure
    Á¤¼ö¾Ð
    ¹°ÀÌ ¾î¶² ³ôÀÌ¿¡¼­µçÁö Á¡¼ö »óÅ¿¡ ÀÖÀ» ¶§ ¹°ÀÇ Á߷¿¡ ÀÇÇØ »ý±â´Â ¾Ð·Â. È帣Áö ¾Ê°í ±«¾î ÀÖ´Â ¹° ¼Ó¿¡ ÀÛ¿ëÇÏ´Â ¾Ð·Â.
  • intra-abdominal pressure
    º¹°­ ³»¾Ð
    º¹°­³» ³»Àå°£ÀÇ ¾Ð·Â.
  • intracranial pressure
    µÎ°³³» ¾Ð
    µÎ°³°ñ°ú ³ú »çÀÌÀÇ °£°Ý¿¡ ÀÖ´Â ¾Ð·Â. ¿¹ÄÁ´ë ÁöÁÖ¸·ÇÏ ¾×ÀÇ ¾Ð·Â.
  • intrapulmonary pressure
    Æó ³»¾Ð
  • intrathecal pressure
    Ãʳ»¾Ð
    ƯÈ÷ ÁöÁÖ¸· ³»ÀÇ ³ú ô¼ö ¾× ¾Ð·Â.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
negative stain <technique> Stain forming an opaque or coloured background against which the object to be demonstrated appears as a translucent or colourless area; in electron microscopy, an electron opaque material, such as phosphotungstic acid or sodium phosphotungstate, is used to give detail as to surface structure.
(05 Mar 2000)
negative staining Microscopic technique in which the object stands out against a dark background of stain. For electron microscopy the sample is suspended in a solution of an electron dense stain such as sodium phosphotungstate and then sprayed onto a support grid. The stain dries as structureless solid and fills all crevices in the sample. When examined in the electron microscope the sample appears as a light object against a dark background. Quite fine structural detail can be observed using negative staining and it has been used extensively to study the structure of viruses and other particulate samples.
(18 Nov 1997)
negative stranded RNA virus <virology> Class V viruses that have an RNA genome that is complementary to the mRNA, the positive strand. They also carry the virus specific RNA polymerase necessary for the synthesis of the mRNA. Includes (Rhabdoviridae, Paramyxoviridae and Myoviridae (for example the T even phages).
(18 Nov 1997)
negative strand virus A virus the genome of which is a strand of RNA that is complementary to messenger RNA; negative strand virus's also carry RNA polymerases necessary for the synthesis of messenger RNA.
(05 Mar 2000)
negative taxis The repulsion of protoplasm away from a stimulus.
(05 Mar 2000)
negative thermotaxis Repulsion of a plant or animal from heat.
(05 Mar 2000)
negative transference Transference characterised by predominantly hostile feelings on the part of the patient toward the analyst.
(05 Mar 2000)
eyepiece, negative <microscopy> An ocular in which the real image of the object is formed between two lenses. The Huygens type.
(05 Aug 1998)
false negative <statistics> A term used to indicate a test showed an incorrect negative result.
(16 Dec 1997)
false-negative reaction <statistics> An erroneous or mistakenly negative response.
Negative test results in subjects who possess the attribute for which the test is conducted. The labeling of diseased persons as healthy when screening in the detection of disease.
(05 Mar 2000)
lens, negative <microscopy> A lens that is thicker on the edges than in the centre, and which causes parallel light rays to diverge.
Synonym: diverging lens.
(05 Aug 1998)
CD4-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the t4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes, which includes both the helper-inducer (T-lymphocytes, helper-inducer) and suppressor-inducer (T-lymphocytes, suppressor-inducer) T-cells.
(12 Dec 1998)
CD8-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-lymphocytes, cytotoxic) and suppressor T-lymphocytes (T-lymphocytes, suppressor-effector).
(12 Dec 1998)
gram-positive <microbiology> Bacteria that retain the stain or that are resistant to decolourisation by alcohol during Gram's method of staining.
This is a primary characteristic of bacteria whose cell wall is composed of a thick layer of peptidologlycan containing teichoic and lipoteichoic acid complexed to the peptidoglycan.
See: gram-negative
(06 Oct 1997)
gram-positive asporogenous rods <microbiology> A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á